Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system. It also provides central pharmacy automation solutions, including automated storage and retrieval systems; IV compounding robots and workflow management systems.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $892.2M | $1.1B | $1.3B | $1.1B | $1.1B | $1.2B |
| Gross profit | $413.3M | $554.7M | $589.0M | $496.8M | $471.0M | $503.4M |
| Operating income | $35.5M | $89.5M | -$2.3M | -$34.9M | $337,000.00 | $5.2M |
| Net income | $32.2M | $77.8M | $5.6M | -$20.4M | $12.5M | $2.1M |
| Diluted EPS | $0.74 | $1.62 | $0.12 | -$0.45 | $0.27 | $0.04 |
| Operating cash flow | $185.9M | $231.8M | $77.8M | $181.1M | $187.7M | $127.3M |
| Free cash flow | $163.0M | $202.8M | $30.2M | $139.6M | $151.3M | $86.9M |
| Gross margin | 46.3% | 49.0% | 45.4% | 43.3% | 42.3% | 42.5% |
| Operating margin | 4.0% | 7.9% | -0.2% | -3.0% | 0.0% | 0.4% |
| Net margin | 3.6% | 6.9% | 0.4% | -1.8% | 1.1% | 0.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $276.8M | $282.4M | $306.9M | $269.7M | $290.6M | $310.6M | $314.0M | $309.9M |
| Gross profit | $114.4M | $122.3M | $141.8M | $110.9M | $127.7M | $134.5M | $130.3M | $140.4M |
| Operating income | $3.2M | $6.6M | $12.4M | -$11.6M | $8.1M | $8.2M | $415,000.00 | $16.9M |
| Net income | $3.7M | $8.6M | $15.8M | -$7.0M | $5.6M | $5.5M | -$2.0M | $11.4M |
| Diluted EPS | $0.08 | $0.19 | $0.34 | -$0.15 | $0.12 | $0.12 | -$0.05 | $0.25 |
| Operating cash flow | $58.7M | $22.8M | $56.3M | $25.9M | $42.8M | $28.3M | $30.4M | $54.5M |
| Free cash flow | $49.1M | $13.9M | $47.2M | $14.8M | $31.0M | $18.5M | $22.6M | $42.1M |
| Gross margin | 41.3% | 43.3% | 46.2% | 41.1% | 43.9% | 43.3% | 41.5% | 45.3% |
| Operating margin | 1.2% | 2.3% | 4.0% | -4.3% | 2.8% | 2.7% | 0.1% | 5.4% |
| Net margin | 1.3% | 3.1% | 5.2% | -2.6% | 1.9% | 1.8% | -0.6% | 3.7% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | LIPPS RANDALL A· CHAIRMAN, CEO | Sale | 10,000 | $47.00 | $470,000.00 | filing |
| 2026-07-01 | Njoku Nnamdi· President & COO | Award | 12,309 | $0.00 | $0.00 | filing |
| 2026-06-01 | Seim Robin Gene | Award | 4,845 | $0.00 | $0.00 | filing |
| 2026-06-01 | Bousa Edward Peter | Award | 4,603 | $0.00 | $0.00 | filing |
| 2026-06-01 | Scott Bruce E | Award | 4,627 | $0.00 | $0.00 | filing |
| 2026-06-01 | Bauer Joanne B | Award | 5,027 | $0.00 | $0.00 | filing |
| 2026-06-01 | Ghoshal Kaushik | Award | 4,603 | $0.00 | $0.00 | filing |
| 2026-06-01 | Garrett Mary | Award | 5,027 | $0.00 | $0.00 | filing |
| 2026-06-01 | PARRISH MARK W | Award | 4,845 | $0.00 | $0.00 | filing |
| 2026-06-01 | Martinson Eileen J. | Award | 4,785 | $0.00 | $0.00 | filing |
| 2026-05-18 | Manley Corey J· EVP&CHIEF LEGAL/ADMIN OFFICER | Sale | 5,025 | $43.22 | $217,180.50 | filing |
| 2026-05-18 | Njoku Nnamdi· EVP, Chief Operating Officer | Sale | 3,090 | $43.22 | $133,549.80 | filing |
| 2026-05-15 | LIPPS RANDALL A· CHAIRMAN, PRESIDENT AND CEO | Tax withholding | 12,347 | $43.12 | $532,402.64 | filing |
| 2026-05-15 | Manley Corey J· EVP&CHIEF LEGAL/ADMIN OFFICER | Tax withholding | 4,041 | $43.12 | $174,247.92 | filing |
| 2026-05-15 | Njoku Nnamdi· EVP, Chief Operating Officer | Tax withholding | 3,660 | $43.12 | $157,819.20 | filing |
| 2026-05-15 | NUTT BRIAN H.· VP, Chief Accounting Officer | Tax withholding | 226 | $43.12 | $9,745.12 | filing |
| 2026-04-01 | LIPPS RANDALL A· CHAIRMAN, PRESIDENT AND CEO | Award | 90,939 | $0.00 | $0.00 | filing |
| 2026-04-01 | Radford Harlan Baird· EVP & Chief Financial Officer | Award | 37,037 | $0.00 | $0.00 | filing |
| 2026-04-01 | NUTT BRIAN H.· VP, Chief Accounting Officer | Award | 5,556 | $0.00 | $0.00 | filing |
| 2026-04-01 | Manley Corey J· EVP&CHIEF LEGAL/ADMIN OFFICER | Award | 25,132 | $0.00 | $0.00 | filing |
| 2026-04-01 | Njoku Nnamdi· EVP, Chief Operating Officer | Award | 46,296 | $0.00 | $0.00 | filing |
| 2026-03-16 | Manley Corey J· EVP&CHIEF LEGAL/ADMIN OFFICER | Sale | 7,405 | $34.69 | $256,879.45 | filing |
| 2026-03-15 | LIPPS RANDALL A· CHAIRMAN, PRESIDENT AND CEO | Tax withholding | 15,642 | $34.40 | $538,084.80 | filing |
| 2026-03-15 | Njoku Nnamdi· EVP, Chief Operating Officer | Tax withholding | 8,456 | $34.40 | $290,886.40 | filing |
| 2026-03-15 | Manley Corey J· EVP&CHIEF LEGAL/ADMIN OFFICER | Tax withholding | 3,819 | $34.40 | $131,373.60 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.